In this randomized controlled trial, supplementation with a strain of the probiotic Lacticaseibacillus casei improved blood glucose and lipid levels and some markers of anthropometrics, inflammation, and oxidative stress, compared to a placebo.
This Study Summary was published on October 30, 2024.
